YOLFTbeta
Jafron Biomedical Co Ltd

Jafron Biomedical Co Ltd

300529 · SHE · Healthcare / Medical Devices

19.69CNY+0.43 (+2.23%)

Price History

Full chart

Market Stats

Previous Close19.26
Open19.14
Day Range19.13 – 19.93
52-Week Range14.73 – 21.65
Volume11.57M
Market Cap12.19B
P/E (TTM)22.79
Forward P/E0.00
EPS0.67
Dividend Yield3.41%
Beta0.31
50-Day Avg16.15
200-Day Avg17.98

About

Jafron Biomedical Co.,Ltd. engages in the research, development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Fan Dong
  • Employees2.20K
  • HeadquartersNo. 98 Technology Six Road, Zhuhai, China, 519085, China
  • Websitehttps://www.jafroninternational.com

Leadership

  • Mr. Fan DongChairman of Board of Directors & GM · b. 1970
  • Ms. Xueyun LiaoDirector & Financial Director · b. 1977
  • Mr. De Zhi LiVice President · b. 1966
  • Ms. Xian Min TangVP & Director · b. 1970
  • Mr. Feng LiVP & Non-Independent Director · b. 1970
  • Mr. Aijun WuVice President · b. 1965
  • Mr. Rui WangGeneral Manager · b. 1962
  • Ms. Cong HuangBoard Secretary · b. 1992

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue194.98M250.62M303.59M370.94M508.91M543.64M718.49M1.02B1.43B1.95B2.68B2.49B1.92B2.68B2.01B
Growth (%)-+28.53%+21.13%+22.18%+37.19%+6.83%+32.16%+41.48%+40.86%+36.24%+37.15%-6.88%-22.84%+39.27%-24.86%
Cost of Revenue34.51M43.86M49.50M56.73M78.73M87.36M113.94M154.49M197.44M288.00M402.12M440.36M390.89M520.26M428.50M
Gross Profit160.47M206.76M254.09M314.21M430.17M456.28M604.55M862.02M1.23B1.66B2.27B2.05B1.53B2.16B1.58B
Gross Margin82.30%82.50%83.69%84.71%84.53%83.93%84.14%84.80%86.21%85.24%84.97%82.32%79.67%80.57%78.70%
Operating Expense74.23M98.56M113.92M140.16M198.13M223.61M272.84M385.71M554.05M608.43M855.41M1.02B987.64M1.11B843.79M
Operating Income86.24M108.20M140.16M174.04M232.04M232.67M331.71M476.31M680.33M1.05B1.42B1.03B543.82M1.05B739.52M
Operating Margin44.23%43.17%46.17%46.92%45.60%42.80%46.17%46.86%47.52%54.05%53.00%41.32%28.29%39.05%36.76%
EBITDA84.29M110.67M142.62M172.68M236.18M240.40M310.71M431.19M634.29M1.00B1.37B995.72M573.43M1.12B836.14M
EBITDA Margin43.23%44.16%46.98%46.55%46.41%44.22%43.25%42.42%44.30%51.38%51.32%39.97%29.83%41.82%41.56%
Net Income75.76M100.02M126.78M160.05M200.44M202.12M284.41M401.98M570.82M875.24M1.20B889.56M436.49M820.20M532.82M
Net Income Margin38.86%39.91%41.76%43.15%39.39%37.18%39.58%39.55%39.87%44.87%44.73%35.70%22.71%30.63%26.48%
R&D9.11M12.82M9.84M15.13M20.51M21.77M26.63M46.14M68.45M80.76M173.77M253.91M245.38M240.09M198.45M
R&D as % of Total Revenue4.67%5.12%3.24%4.08%4.03%4.00%3.71%4.54%4.78%4.14%6.50%10.19%12.76%8.97%9.86%
Interest Expense0038.20K37.87K50.03K64.87K93.03K140.57K233.50K1.29M14.55M36.51M55.29M64.22M53.51M
Interest Expense % of Total Revenue0.00%0.00%0.01%0.01%0.01%0.01%0.01%0.01%0.02%0.07%0.54%1.47%2.88%2.40%2.66%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets246.24M341.58M461.73M539.01M688.67M1.30B1.70B2.05B2.49B3.22B4.81B5.41B5.54B5.38B5.41B
Total Liabilities30.68M50.74M81.60M86.59M124.61M115.81M310.90M330.04M324.13M383.06M1.43B1.82B2.39B2.05B1.94B
Total Equity215.57M290.84M380.12M452.42M564.06M1.18B1.39B1.70B2.14B2.81B3.36B3.57B3.15B3.33B3.47B
Cash175.28M217.36M248.37M232.85M287.49M760.08M1.06B1.08B1.27B1.58B2.32B2.56B2.81B1.72B2.52B
Total Debt------137.40M107.17M59.65M30.24M917.55M1.28B1.65B1.19B-
Net Debt-175.28M-217.36M-248.37M-232.85M-287.49M-760.08M-924.26M-973.63M-1.21B-1.54B-1.40B-1.28B-1.14B-532.27M-

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow77.06M120.25M133.33M137.35M205.18M178.64M304.10M384.08M583.50M957.49M1.25B883.80M916.74M1.05B721.22M
Investing Cash Flow-19.58M-52.25M-60.99M-65.12M-61.90M-126.44M-59.33M-254.93M-197.12M-341.11M-670.22M-305.90M-249.65M-1.13B-
Financing Cash Flow13.38M-24.75M-37.50M-87.75M-88.80M420.56M56.31M-114.51M-195.44M-313.03M165.18M-365.93M-451.91M-989.82M-
Capital Expenditure14.58M53.43M63.14M64.29M61.40M28.66M177.73M173.53M220.67M357.11M537.41M475.89M247.25M235.14M172.59M
Free Cash Flow62.48M66.82M70.18M73.06M143.78M149.98M126.37M210.55M362.82M600.37M712.00M407.91M669.49M815.85M548.63M
Dividends Paid5.61M24.75M37.50M87.75M88.80M83.32M83.32M146.16M251.01M377.81M531.02M716.99M561.79M340.12M643.57M
FCF to OCF81.08%55.57%52.64%53.19%70.07%83.96%41.56%54.82%62.18%62.70%56.99%46.15%73.03%77.63%76.07%
Dividend Paid to FCF8.98%37.04%53.43%120.10%61.76%55.55%65.94%69.42%69.18%62.93%74.58%175.77%83.91%41.69%117.31%

Earnings

Report DateOct 27, 2016Jan 15, 2017Apr 26, 2017Aug 29, 2017Oct 27, 2017Apr 17, 2018Aug 2, 2018Oct 23, 2018Feb 13, 2019Apr 15, 2019Aug 27, 2019Oct 29, 2019Feb 5, 2020Apr 15, 2020Aug 25, 2020Oct 20, 2020Apr 12, 2021Aug 2, 2021Oct 26, 2021Apr 11, 2022Aug 25, 2022Oct 27, 2022Mar 30, 2023Apr 27, 2023Aug 18, 2023Oct 26, 2023Apr 25, 2024Aug 7, 2024Oct 18, 2024Dec 31, 2024Apr 15, 2025Aug 22, 2025Oct 30, 2025Apr 29, 2026Aug 10, 2026
EPS Estimate-----------------------0.27-0.20--0.280.230.38----
EPS Actual0.050.080.080.110.070.110.150.120.120.160.220.140.200.230.320.230.350.430.300.420.510.150.020.230.100.170.350.330.280.090.230.260.080.280.20
Surprise------------------------14.81%--15.00%--0.00%-61.43%-39.47%----
TimingPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-market-After-hours----

Key Statistics & Ratios

Market Cap12.19B
Enterprise Value10.97B
Trailing P/E22.79
Forward P/E0.00
Price / Sales6.39
Price / Book3.50
EPS0.67
Book Value4.47
Revenue (TTM)1.91B
Gross Profit (TTM)1.47B
EBITDA793.28M
Profit Margin27.49%
Operating Margin36.80%
Return on Equity15.98%
Return on Assets8.09%
Shares Outstanding798.61M
Shares Float374.61M
Beta0.31
Dividend Yield3.41%
Dividend Rate0.52
Payout Ratio92.86%

Dividends

20261×
0.52Jun 1, 2026
20251×
0.80May 26, 2025
20241×
0.40May 31, 2024
20231×
0.67May 31, 2023
20221×
0.90Jun 10, 2022
20211×
0.66May 12, 2021
20201×
0.47May 20, 2020
20191×
0.32May 13, 2019
20181×
0.18Jun 8, 2018
20171×
0.11Jun 13, 2017

Stock Splits

  • May 20, 20201.9:1